Skip to main content
. 2009;11(5):237–244. doi: 10.4088/PCC.08m00680

Table 1.

Summary of 4 Randomized, Double-Blind, Placebo-Controlled Studies of Duloxetine for the Treatment of Fibromyalgia

Study Treatment Duration Dose Duloxetine (n) Placebo (n) Primary Efficacy Measures
118 12 wk 60 mg bid 104 103 FIQ total score
FIQ pain score
219 12 wk 60 mg qd 118 120 BPI 24-h average pain score
60 mg bid 116
320 28 wk 20 mg qd 79 144 BPI 24-h average pain score
60 mg qd 150 PGI-I score
120 mg qd 147
421 28 wk 60/120 mg qd 162 168 BPI 24-h average pain score
PGI-I score

Abbreviations: bid = twice daily, BPI = Brief Pain Inventory FIQ = Fibromyalgia Impact Questionnaire, PGI-I = Patient Global Impressions-Improvement scale, qd = once daily.

HHS Vulnerability Disclosure